2IPE - Header Asymmetric Unit

HEADER 12-OCT-06 2IPE

TITLE BIK

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN BCL-2L13 PRO-APOPTOTIC PROTEIN COMPND 3 TRANSMEMBRANE PROTEIN; COMPND 4 CHAIN: NULL

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 OTHER_DETAILS: B-CELL, LYMPH

KEYWDS BCL-2L13,BCL INTERACTING KILLER, PRO-APOPTOTIC PROTEIN, KEYWDS 2 TRANSMEMBRANE PROTEIN, APOPTOSIS

EXPDTA THEORETICAL MODEL

AUTHOR BHARGAVI KONDAGARI,KALYAN CHAITANYA PULIPAKA,RAMAKRISHNA AUTHOR 2 ANNABHIMOJU,UMA VURUPUTURI,K.MURTHY DWARKANATH

REVDAT 1 24-OCT-06 2IPE 0

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SCHRONDIGER 2005 REMARK 3 AUTHORS : D.E.SHAW REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 2IPE COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998

REMARK 100 REMARK 100 THIS ENTRY WAS DEPOSITED AT RCSB ON 12-OCT-2006. REMARK 100 THE RCSB ID CODE IS RCSB039851.

REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THIS THEORETICAL MODEL ENTRY WAS NOT ANNOTATED AND NOT REMARK 220 VALIDATED BY THE WWPDB STAFF AND THEREFORE MAY NOT REMARK 220 CONFORM TO THE PDB FORMAT.

REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.

REMARK 888 REMARK 888 WRITTEN BY MAESTRO (A PRODUCT OF SCHRODINGER, LLC)

SEQRES 1 160 MET SER GLU VAL ARG PRO LEU SER ARG ASP ILE LEU MET SEQRES 2 160 GLU THR LEU LEU TYR GLU GLN LEU LEU GLU PRO PRO THR SEQRES 3 160 MET GLU VAL LEU GLY MET THR ASP SER GLU GLU ASP LEU SEQRES 4 160 ASP PRO MET GLU ASP PHE ASP SER LEU GLU CYS MET GLU SEQRES 5 160 GLY SER ASP ALA LEU ALA LEU ARG LEU ALA CYS ILE GLY SEQRES 6 160 ASP GLU MET ASP VAL SER LEU ARG ALA PRO ARG LEU ALA SEQRES 7 160 GLN LEU SER GLU VAL ALA MET HIS SER LEU GLY LEU ALA SEQRES 8 160 PHE ILE TYR ASP GLN THR GLU ASP ILE ARG ASP VAL LEU SEQRES 9 160 ARG SER PHE MET ASP GLY PHE THR THR LEU LYS GLU ASN SEQRES 10 160 ILE MET ARG PHE TRP ARG SER PRO ASN PRO GLY SER TRP SEQRES 11 160 VAL SER CYS GLU GLN VAL LEU LEU ALA LEU LEU LEU LEU SEQRES 12 160 LEU ALA LEU LEU LEU PRO LEU LEU SER GLY GLY LEU HIS SEQRES 13 160 LEU LEU LEU LYS

HELIX 1 1 VAL 4 LEU 12 1 9 HELIX 2 2 PRO 25 ASP 34 1 10 HELIX 3 3 MET 51 LEU 61 1 11 HELIX 4 4 SER 81 MET 85 1 5 HELIX 5 5 THR 97 PHE 107 1 11 HELIX 6 6 ASN 126 GLN 135 1 10 HELIX 7 7 LEU 147 SER 152 1 6 HELIX 8 8 GLY 154 LEU 159 1 6

SHEET 1 A 3 GLU 49 CYS 50 0 SHEET 2 A 3 ASP 66 ARG 73 -1 O SER 71 N GLU 49 SHEET 3 A 3 HIS 86 ILE 93 -1 O ALA 91 N MET 68

CISPEP 1 PHE 45 ASP 46 0 13.34

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000